Christopher Twomey
Director/Board Member presso TANDEM DIABETES CARE, INC.
Patrimonio netto: 698 858 $ in data 31/03/2024
Posizioni attive di Christopher Twomey
Società | Posizione | Inizio | Fine |
---|---|---|---|
TANDEM DIABETES CARE, INC. | Director/Board Member | 01/07/2013 | - |
Independent Dir/Board Member | 01/07/2013 | - | |
BIONANO GENOMICS, INC. | Director/Board Member | 01/07/2018 | - |
Independent Dir/Board Member | 01/07/2018 | - |
Storia della carriera di Christopher Twomey
Precedenti posizioni note di Christopher Twomey
Società | Posizione | Inizio | Fine |
---|---|---|---|
CADENCE PHARMACEUTICALS, INC. | Director/Board Member | 01/07/2006 | 19/03/2014 |
Independent Dir/Board Member | 24/11/2011 | 19/03/2014 | |
Biosite, Inc. (Massachusetts) | Director of Finance/CFO | 01/03/1990 | 01/06/2007 |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/03/1990 | 01/01/2007 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/10/1981 | 01/03/1990 |
SENOMYX INC. | Director/Board Member | 17/03/2006 | - |
Independent Dir/Board Member | 17/03/2006 | - |
Formazione di Christopher Twomey
University of California, Santa Barbara | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Sud Africa | 2 |
Posizioni
Director/Board Member | 4 |
Independent Dir/Board Member | 4 |
Director of Finance/CFO | 2 |
Settori
Health Technology | 5 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
TANDEM DIABETES CARE, INC. | Health Technology |
BIONANO GENOMICS, INC. | Health Technology |
Aziende private | 5 |
---|---|
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Senomyx, Inc.
Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
Mallinckrodt Hospital Products, Inc.
Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
Biosite, Inc. (Massachusetts) |
- Borsa valori
- Insiders
- Christopher Twomey
- Esperienza